Uwe Schlomann

1.4k citations
28 papers · 945 indexed · h-index 17
Topics
Cell Adhesion Molecules Research (11 papers)Peptidase Inhibition and Analysis (9 papers)HER2/EGFR in Cancer Research (7 papers)

In The Last Decade

Uwe Schlomann

28 papers receiving 931 citations

Peers

Uwe Schlomann
Comparison fields: 5 of 79
  • Molecular Biology 466
  • Oncology 307
  • Immunology and Allergy 250
  • Cancer Research 211
  • Cell Biology 115
Replace Qiqun Zeng with:
Qiqun Zeng China
Jean Kloss United States
Yigong Fu United States
Nora P. Dooley Canada
Kristine Kelly United States
Barbara Blouw United States
Naoko Kogata United Kingdom
Rafaela Cañete-Soler United States
R M de Waal Netherlands
C. Leann Hinkle United States
Uwe Schlomann relative to Qiqun Zeng China Qiqun Zeng's profile →
Citations per field
00.5×1.5×2.4×
Qiqun Zeng · 1×
Citations per year

Countries citing papers authored by Uwe Schlomann

Since Specialization
Citations

This map shows the geographic impact of Uwe Schlomann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uwe Schlomann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uwe Schlomann more than expected).

Fields of papers citing papers by Uwe Schlomann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Uwe Schlomann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uwe Schlomann. The network helps show where Uwe Schlomann may publish in the future.

Co-authorship network of co-authors of Uwe Schlomann

This figure shows the co-authorship network connecting the top 25 collaborators of Uwe Schlomann. A scholar is included among the top collaborators of Uwe Schlomann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Uwe Schlomann. Uwe Schlomann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 19
3 16
4 47
5 57
6 6
7 45
8 13
9 15
10 8
11 52
12 80
13 52
14 1
15 35
16 58
17 27
18 137
19 31
20 110

About Uwe Schlomann

Uwe Schlomann is a scholar working on Immunology and Allergy, Cancer Research and Oncology, having authored 28 papers that have together received 945 indexed citations. Recurring topics across this work include Cell Adhesion Molecules Research (11 papers), Peptidase Inhibition and Analysis (9 papers) and HER2/EGFR in Cancer Research (7 papers). The work is most often cited by research in Immunology and Allergy (250 citations), Cancer Research (211 citations) and Oncology (307 citations). Uwe Schlomann has collaborated with scholars based in Germany, United Kingdom and United States. Frequent co-authors include Jörg W. Bartsch, Harald Jockusch, Silvia Rathke‐Hartlieb, Christopher Nimsky, Shunsuke Yamamoto, Catharina Conrad, Barbara Carl, Julia Benzel, Andrew Docherty and Dirk Wildeboer. Their work appears in journals such as Journal of Biological Chemistry, Journal of Neuroscience and Analytical Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026